Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on June 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

High Sensitivity Immunoassay Plate Reader

Closed
26-58035International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Research Council of Canada, Human Health Therapeutics, is seeking a High Sensitivity Immunoassay Plate Reader through a sole-source procurement justified by the exclusive technical capability of Meso Scale Discovery Inc. to meet all mandatory performance requirements. The instrument must detect analytes at concentrations as low as picogram per milliliter, deliver a linear dynamic range of at least four orders of magnitude, and maintain intra- and inter-assay precision with a coefficient of variation no greater than 10 percent. It must be compatible with complex biological matrices including serum, cerebrospinal fluid, tissue lysates, and cell lysates, while supporting 96-well plate formats and the ability to load and process at least three plates simultaneously. Multiplex analysis of multiple analytes within a single sample is required, along with the flexibility to design assays without reliance on proprietary consumables. Full data traceability, including comprehensive run logs and audit trails, is essential for regulatory compliance and reproducibility. Delivery of the system is to be completed within 60 calendar days of contract award at a location in Canada, with no specified delivery terms or packaging requirements outlined. The solicitation, identified by number 26-58035, was posted on June 11, 2026, with a final response deadline of the same day at 2:00 p.m. EST, allowing other suppliers to submit a Statement of Capabilities to challenge the sole-source determination. Despite the absence of pricing data, contract value, or formal clauses under FAR or DFARS, the award hinges entirely on technical compliance, with no scoring, weighting, or cost evaluation applied. The contracting authority, Helen Tran of the NRC, is the sole point of contact for submissions and inquiries, and the procurement is governed under the Canadian Free Trade Agreement, invoking an exception for technological exclusivity. No intellectual property transfer, security clearances, or socioeconomic set-asides are referenced, and the acquisition is structured to ensure rapid deployment of a system proven to meet non-negotiable analytical standards.

General Info

High sensitivity immunoassay reader for low-abundance analytes, multiplexing, 96-well compatibility.

Agency

Government of Canada → National Research Council of CanadaView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

(2)

26-58035 PAC Microplate Reader for High Sensitivity Immunoassays

PDFpresolicitation

26-58035 Advance Contract Award Notice for High Sensitivity Immunoassay Plate Reader

PDFacan

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → National Research Council of Canada
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → National Research Council of Canada
View Agency Profile
Office AddressN/A
Contacts
Helen TranPoint of Contact

Full Description

Show more
The National Research Council, Human Health Therapeutics (NRC – HHT) requires a High Sensitivity Immunoassay Plate Reader capable of quantifying low-abundance biologics and biomarkers in complex biological matrices. The instrument must provide high sensitivity, broad dynamic range, multiplex capability, and compatibility with small sample volumes. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that its system meets the following performance-based requirements: • Detect analytes at low picogram/mL concentrations. • Provide a linear dynamic range spanning at least four orders of magnitude. • Provide intra- and inter-assay precision with coefficient of variation (CV) = 10%. • Be compatible with serum, cerebrospinal fluid, tissue lysates, and cell lysates. • Support at least 96-well plates and load a minimum of three plates. • Support multiplex analysis of multiple analytes in a single sample. • Allow flexible assay design without requiring proprietary consumables. • Provide data traceability including run logs and audit trails.

More opportunities from Government of Canada → National Research Council of Canada

Same awarding agency